Europe revokes marketing authorization for generic versions of Biogen's MS drug

Biogen Inc (BIIB.O) said on Tuesday the European Commission has revoked the marketing authorization for generic versions of its multiple sclerosis drug Tecfidera held by the firms Accord, Neuraxpharm, Polpharma and Teva (TEVA.TA).